GPC1 and pachyonychia congenita: Melo et al. demonstrated that the presence of circulating GPC1+ EXOs (GPC1+crEXOs) in the serum of PC patients enables the distinguishment between healthy donors and PC patients, as well as between early or late-stage patients.